ERBB2 and breast cancer: We then used BONOBO to infer sample-specific coexpression networks to explore how correlation between miRNA and gene expression vary between breast cancer subtypes (normal-like, Luminal A, Luminal B, ERBB2/HER2-positive, and basal) and whether patterns of coexpression can be used to predict survival outcomes.